HOME › DRUGS › SORAFENIB
ACTIVE SUBSTANCE / INN

SORAFENIB

Brand name(s): Sorafenib Accord, Nexavar
EMA LISTED
AUTHORISED
Carcinoma, Hepatocellular;Carcinoma, Renal Cell
ACTIVE SUBSTANCE
Sorafenib
REGULATORS
EMA
SPONSORS / MAH
Accord Healthcare S.L.U., Bayer AG
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Sorafenib AccordAccord Healthcare S.L.U.Authorised09/11/2022Carcinoma, Hepatocellular;Carcinoma, Renal Cell
NexavarBayer AGAuthorised19/07/2006Carcinoma, Hepatocellular;Carcinoma, Renal Cell

FULL INTELLIGENCE ON SORAFENIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →